Community Healthcare Trust Incorporated (CHCT) Key Metrics
CHCT valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $379.4M
- Enterprise value
- $974.1M
- P/E (TTM)
- 20.4 10-yr median 87.0
- Forward P/E
- 37.3
- PEG ratio
- —
- Price / sales
- 3.0 10-yr median 10.4
- Price / book
- 1.0 10-yr median 1.6
- EV / EBITDA
- 10.4 10-yr median 18.9
- Dividend yield
- 13.29% $1.76 a year
- Beta
- 0.65
CHCT key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCHCT valuation Price multiples at each fiscal year-end price.
CHCT returns How much profit the business earns on the capital it uses.
CHCT per-share figures Results divided by the shares outstanding at year-end.
CHCT financial health Debt, liquidity and how easily interest is covered.
CHCT efficiency & capital use Working capital cycle and where the cash goes.
CHCT valuation history
CHCT returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CHCT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CHCT cash returned to shareholders
CHCT price vs earnings per share
CHCT key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $441.0M | $509.6M | $671.4M | $846.0M | $1.10B | $1.02B | $800.8M | $509.4M | $416.3M | $260.7M |
| Enterprise value | $973.8M | $995.2M | $1.08B | $1.19B | $1.37B | $1.26B | $1.01B | $698.1M | $507.5M | $310.1M |
| P/E ratio | 86.4 | — | 87.0 | 38.4 | 48.9 | 53.3 | 95.6 | 115.7 | 118.6 | 95.8 |
| Price / sales | 3.6 | 4.4 | 5.9 | 8.7 | 12.1 | 13.4 | 13.2 | 10.5 | 11.1 | 10.3 |
| Price / book | 1.0 | 1.1 | 1.3 | 1.7 | 2.4 | 2.4 | 2.3 | 1.9 | 1.5 | 1.3 |
| Price / free cash flow | 12.3 | 14.9 | 15.8 | 17.0 | 22.4 | 24.6 | 28.6 | 25.6 | 19.8 | 19.5 |
| Price / operating cash flow | 7.8 | 8.7 | 10.9 | 14.0 | 19.5 | 21.0 | 24.7 | 20.8 | 18.8 | 17.5 |
| EV / sales | 8.0 | 8.6 | 9.6 | 12.2 | 15.2 | 16.6 | 16.6 | 14.4 | 13.6 | 12.3 |
| EV / EBITDA | 11.8 | 15.7 | 16.3 | 17.7 | 21.3 | 23.6 | 24.1 | 23.8 | 19.9 | 18.0 |
| EV / free cash flow | 27.1 | 29.1 | 25.5 | 23.8 | 28.0 | 30.4 | 36.0 | 35.1 | 24.2 | 23.2 |
| Earnings yield | 1.2% | −0.6% | 1.1% | 2.6% | 2.0% | 1.9% | 1.0% | 0.9% | 0.8% | 1.0% |
| Free cash flow yield | 8.1% | 6.7% | 6.3% | 5.9% | 4.5% | 4.1% | 3.5% | 3.9% | 5.0% | 5.1% |
| Dividend yield | 12.2% | 10.1% | 7.2% | 5.3% | 3.9% | 3.7% | 4.0% | 5.8% | 5.9% | 6.8% |
| Shareholder yield (dividends + buybacks) | 12.6% | 10.1% | 7.3% | 5.3% | 3.9% | 3.7% | 4.0% | 5.8% | 5.9% | 6.8% |
| Share price at fiscal year-end | $16.42 | $19.21 | $26.64 | $35.80 | $47.27 | $47.11 | $42.86 | $28.83 | $28.10 | $23.03 |
| Per share | ||||||||||
| Revenue per share | $4.51 | $4.36 | $4.48 | $4.13 | $3.89 | $3.51 | $3.26 | $2.75 | $2.52 | $2.23 |
| Earnings per share | $0.19 | −$0.12 | $0.31 | $0.93 | $0.97 | $0.88 | $0.45 | $0.25 | $0.24 | $0.24 |
| Operating cash flow per share | $2.10 | $2.22 | $2.44 | $2.55 | $2.42 | $2.24 | $1.73 | $1.38 | $1.49 | $1.32 |
| Free cash flow per share | $1.34 | $1.29 | $1.68 | $2.11 | $2.11 | $1.92 | $1.50 | $1.13 | $1.42 | $1.18 |
| Cash per share | $0.12 | $0.17 | $0.14 | $0.48 | $0.10 | $0.12 | $0.09 | $0.11 | $0.14 | $0.14 |
| Book value per share | $15.99 | $17.94 | $20.37 | $21.02 | $19.86 | $19.93 | $18.91 | $15.38 | $19.13 | $17.14 |
| Tangible book value per share | $15.94 | $17.87 | $20.26 | $20.92 | $19.84 | $19.90 | $18.91 | $15.37 | −$4.09 | $17.14 |
| Dividends per share | $2.00 | $1.95 | $1.91 | $1.88 | $1.82 | $1.76 | $1.71 | $1.66 | $1.65 | $1.57 |
| Capex per share | $0.76 | $0.93 | $0.75 | $0.44 | $0.31 | $0.32 | $0.23 | $0.26 | $0.08 | $0.14 |
| Debt per share | $19.96 | $18.47 | $16.36 | $14.94 | $11.93 | $11.37 | $11.20 | $10.80 | $6.30 | $4.51 |
| Shares outstanding | 26.9M | 26.5M | 25.2M | 23.6M | 23.3M | 21.6M | 18.7M | 17.7M | 14.8M | 11.3M |
| Change in shares outstanding | +1.2% | +5.3% | +6.6% | +1.6% | +7.8% | +15.5% | +5.8% | +19.3% | +30.9% | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 1.1% | −0.6% | 1.5% | 4.6% | 5.0% | 4.9% | 2.7% | 1.6% | 1.5% | 1.7% |
| Return on invested capital (ROIC) | 2.1% | 1.7% | 2.7% | 4.3% | 4.6% | 4.5% | 3.1% | 3.2% | 1.2% | 1.0% |
| Return on assets (ROA) | 0.5% | −0.3% | 0.8% | 2.7% | 3.2% | 3.1% | 1.7% | 1.1% | 1.1% | 1.4% |
| Return on tangible assets | 0.5% | −0.3% | 0.8% | 2.5% | 3.0% | 2.9% | 1.5% | 1.0% | 8.4% | 1.1% |
| Free cash flow margin | 29.6% | 29.6% | 37.6% | 51.1% | 54.2% | 54.7% | 46.0% | 40.9% | 56.2% | 53.0% |
| Income quality (OCF / net income) | 11.06 | — | 7.96 | 2.74 | 2.51 | 2.54 | 3.86 | 5.55 | 6.30 | 5.49 |
| Financial health | ||||||||||
| Total debt | $536.2M | $490.0M | $412.3M | $353.1M | $277.6M | $245.4M | $209.2M | $190.8M | $93.4M | $51.0M |
| Cash & short-term investments | $3.3M | $4.4M | $3.5M | $11.2M | $2.4M | $2.5M | $1.7M | $2.0M | $2.1M | $1.6M |
| Net debt | $532.9M | $485.6M | $408.8M | $341.9M | $275.3M | $242.9M | $207.5M | $188.8M | $91.2M | $49.4M |
| Debt / equity | 1.25 | 1.03 | 0.80 | 0.71 | 0.60 | 0.57 | 0.59 | 0.70 | 0.33 | 0.26 |
| Debt / assets | 0.54 | 0.49 | 0.44 | 0.40 | 0.37 | 0.37 | 0.37 | 0.45 | 0.24 | 0.20 |
| Net debt / EBITDA | 6.44 | 7.67 | 6.17 | 5.09 | 4.27 | 4.56 | 4.96 | 6.44 | 3.57 | 2.87 |
| Current ratio | 0.17 | 0.25 | 5.74 | 1.06 | 0.37 | 0.77 | 0.56 | 0.70 | 7.72 | 3.49 |
| Quick ratio | 0.17 | 0.25 | 4.21 | 3.05 | 0.41 | −0.01 | −0.08 | 0.72 | 7.79 | 3.56 |
| Interest coverage | 0.6 | 0.8 | 1.4 | 2.9 | 3.1 | 3.2 | 2.0 | 2.1 | 1.9 | 3.3 |
| Working capital | −$231.5M | −$174.7M | $58.0M | $691,000 | −$5.0M | −$9.5M | −$1.6M | −$13.8M | $27.3M | $8.8M |
| Invested capital | $962.2M | $961.6M | $922.0M | $838.7M | $737.4M | $672.8M | $560.9M | $460.4M | $374.6M | $243.4M |
| Tangible asset value | $428.1M | $474.0M | $510.6M | $494.4M | $461.5M | $429.3M | $353.3M | $271.5M | −$60.6M | $194.0M |
| Net current asset value | −$513.9M | −$458.5M | −$361.9M | −$367.5M | −$289.3M | −$206.6M | −$207.1M | −$122.5M | −$71.1M | −$45.2M |
| Graham number | $8.27 | — | $11.84 | $20.99 | $20.79 | $19.91 | $13.81 | $9.28 | $10.10 | $9.63 |
| Graham net-net per share | −$19.74 | −$18.03 | −$14.94 | −$14.36 | −$11.07 | −$9.20 | −$9.76 | −$7.43 | −$5.32 | −$4.24 |
| Capital allocation | ||||||||||
| Dividends paid | $53.7M | $51.7M | $48.1M | $44.5M | $42.4M | $38.0M | $31.9M | $29.4M | $24.4M | $17.8M |
| Share buybacks (net) | $1.8M | — | $963,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividend payout ratio | — | — | 623.0% | 202.0% | 188.5% | 199.4% | 381.4% | 667.2% | 696.1% | 653.5% |
| Dividends + buybacks / free cash flow | 154.5% | 151.0% | 115.6% | 89.1% | 86.3% | 91.9% | 114.1% | 147.7% | 116.4% | 133.2% |
| Capex / revenue | 16.9% | 21.3% | 16.8% | 10.6% | 8.0% | 9.2% | 7.2% | 9.4% | 3.0% | 6.3% |
| Capex / operating cash flow | 36.4% | 41.9% | 30.9% | 17.2% | 12.8% | 14.5% | 13.5% | 18.6% | 5.1% | 10.6% |
| Capex / depreciation | 0.47 | 0.58 | 0.47 | 0.31 | 0.23 | 0.27 | 0.19 | 0.23 | 0.06 | 0.12 |
| Stock-based compensation / revenue | 8.5% | 8.6% | 17.7% | 9.6% | 7.9% | 6.3% | 6.3% | 5.9% | 3.9% | 2.7% |
| R&D / revenue | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A / revenue | 20.7% | 16.5% | 24.2% | 15.2% | 13.4% | 11.6% | 12.7% | 11.7% | 9.3% | 12.8% |
| Efficiency | ||||||||||
| Days sales outstanding | 124.4 | 161.1 | 179.2 | 181.2 | 144.1 | 145.1 | 183.9 | 219.1 | 193.7 | 157.0 |
| Days of inventory on hand | — | — | -34.7 | -252.4 | 384.6 | 463.8 | 21.1 | -21.3 | -10.9 | -10.0 |
| Days payables outstanding | 48.2 | 210.4 | 206.3 | 210.9 | 163.6 | 125.3 | 101.5 | 133.1 | 159.7 | 167.5 |
| Cash conversion cycle (days) | 76.2 | -49.2 | -61.8 | -282.1 | 365.0 | 483.6 | 103.5 | 64.7 | 23.1 | -20.4 |
| Receivables turnover | 2.93 | 2.27 | 2.04 | 2.01 | 2.53 | 2.52 | 1.98 | 1.67 | 1.88 | 2.32 |
| Payables turnover | 7.58 | 1.74 | 1.77 | 1.73 | 2.23 | 2.91 | 3.60 | 2.74 | 2.29 | 2.18 |
| Inventory turnover | — | — | — | — | — | 0.79 | 17.31 | — | — | — |
| Asset turnover | 0.12 | 0.12 | 0.12 | 0.12 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.13 |
| Average receivables | $41.3M | $51.1M | $55.4M | $48.5M | $35.7M | $30.1M | $30.7M | $29.2M | $19.8M | $10.8M |
| Average payables | $14.6M | $13.2M | $11.7M | $9.6M | $6.8M | $4.7M | $3.4M | $3.6M | $3.8M | $2.2M |
| Average inventory | — | — | −$2.0M | −$11.5M | $16.0M | $17.3M | $707,000 | −$580,000 | −$259,000 | −$130,000 |
| Intangibles / total assets | 0.1% | 0.2% | 0.3% | 0.3% | 0.1% | 0.1% | 0.0% | 0.0% | 89.2% | 0.0% |
Computed from CHCT's annual financial statements (latest annual report filed February 17, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CHCT valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Community Healthcare traded at 86.4 times earnings, against a 10-year median of 87.0. Based on the latest twelve months, the trailing P/E is 20.4 and the forward P/E is 37.3. Community Healthcare earned a return on equity of 1.1% and a return on invested capital of 2.1% in fiscal 2025. It ended the year with $536.2 million of debt and $3.3 million in cash and short-term investments, net debt of $532.9 million. It returned $55.5 million to shareholders: $53.7 million in dividends and $1.8 million in share buybacks, 154% of free cash flow. The share count rose 137.3% from 11.3M to 26.9M over 9 years.
See the CHCT income statement, the CHCT chart for price history, or the CHCT stock overview for the latest quote and news.
CHCT key metrics FAQ
What is Community Healthcare's P/E ratio?
Community Healthcare's trailing P/E ratio is 20.4 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 37.3. At the end of fiscal 2025 it was 86.4, compared with a 10-year median of 87.0.
What is Community Healthcare's EV/EBITDA?
Community Healthcare's enterprise value was 11.8 times EBITDA at the end of fiscal 2025 (enterprise value $973.8 million, EBITDA $82.7 million); the current EV/EBITDA is 10.4.
What is Community Healthcare's return on equity?
Community Healthcare's return on equity (ROE) was 1.1% in fiscal 2025: net income of $5.1 million on average shareholders' equity of $452.7 million.
What is Community Healthcare's ROIC?
Community Healthcare's return on invested capital was 2.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Community Healthcare have?
Community Healthcare had total debt of $536.2 million at the end of fiscal 2025, a debt-to-equity ratio of 1.25 and $532.9 million of net debt (6.44 times EBITDA).
What is Community Healthcare's dividend yield?
Community Healthcare's forward dividend yield is 13.29%. Community Healthcare paid $53.7 million in dividends in fiscal 2025 ($2.00 per share), a payout ratio of —.
Does Community Healthcare buy back its shares?
Yes. Community Healthcare spent $1.8 million on net share repurchases in fiscal 2025 Shares outstanding changed +1.2% over the year, to 26.9M..
What is Community Healthcare's free cash flow yield?
Community Healthcare generated $35.9 million of free cash flow in fiscal 2025, a free cash flow yield of 8.1% on its market value at year-end ($441.0 million).
What is Community Healthcare's current ratio?
Community Healthcare's current ratio was 0.17 at the end of fiscal 2025: current assets were 0.17 times current liabilities.